Last update 08 May 2025

ERC-124

Overview

Basic Info

Drug Type
Stem cell therapy
Synonyms
Endometrial blood stem cell therapy Intrexon, Endometrial regenerative cells
+ [1]
Target
IFNGR
Action
antagonists
Mechanism
IFNGR antagonists(Interferon gamma receptor antagonists)
Therapeutic Areas
Cardiovascular DiseasesImmune System DiseasesNervous System Diseases+ [3]
Active Indication-
Inactive Indication
Brain InjuriesDiabetes Mellitus, Type 1Heart Failure+ [4]
Originator Organization
Medistem, Inc.Medistem, Inc.Yale UniversityYale University
Active Organization-
Inactive Organization
Precigen, Inc.Precigen, Inc.ERCell LLCYale UniversityYale University
+ [2]
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with ERC-124
Login to view more data
100 Translational Medicine associated with ERC-124
Login to view more data
100 Patents (Medical) associated with ERC-124
Login to view more data
100 Deals associated with ERC-124
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Peripheral Vascular DiseasesPhase 2
China
Medistem, Inc.Medistem, Inc.
16 Jul 2012
Diabetes Mellitus, Type 1Phase 2
United States
Yale UniversityYale University
-
Diabetes Mellitus, Type 1Phase 2
Russia
ERCell LLC
-
Diabetes Mellitus, Type 1Phase 2
United States
The Brigham & Women's Hospital, Inc.The Brigham & Women's Hospital, Inc.
-
Diabetes Mellitus, Type 1Phase 2
Russia
ERCell LLC
-
Diabetes Mellitus, Type 1Phase 2
Russia
Precigen, Inc.Precigen, Inc.
-
Diabetes Mellitus, Type 1Phase 2
United States
Yale UniversityYale University
-
Diabetes Mellitus, Type 1Phase 2
United States
The Brigham & Women's Hospital, Inc.The Brigham & Women's Hospital, Inc.
-
Heart FailurePhase 2
Russia
Precigen, Inc.Precigen, Inc.
-
Perioperative ischaemiaPhase 2
China
Precigen, Inc.Precigen, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free